Cite

HARVARD Citation

    Kayser, S. et al. (2017). Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis. Expert review of clinical pharmacology. 10 (11), pp. 1177-1189. [Online]. 
  
Back to record